These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 16507539

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Preclinical restenosis models and drug-eluting stents: still important, still much to learn.
    Schwartz RS, Chronos NA, Virmani R.
    J Am Coll Cardiol; 2004 Oct 06; 44(7):1373-85. PubMed ID: 15464316
    [Abstract] [Full Text] [Related]

  • 3. Pathophysiology of coronary artery restenosis.
    Schwartz RS, Henry TD.
    Rev Cardiovasc Med; 2002 Oct 06; 3 Suppl 5():S4-9. PubMed ID: 12478229
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Restenosis is not associated with stent length in a pig model of coronary stent implantation.
    Koutouzis M, Papalois A, Kyrzopoulos S, Dafnomili P, Kyriakides ZS.
    Cardiol J; 2008 Oct 06; 15(5):458-62. PubMed ID: 18810722
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preclinical models of restenosis and their application in the evaluation of drug-eluting stent systems.
    Perkins LE.
    Vet Pathol; 2010 Jan 06; 47(1):58-76. PubMed ID: 20080486
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biocompatibility of tetramethylpyrazine-eluting stents in normal porcine coronary arteries.
    Ma GS, Chen LJ, Chen Z, Ding S, Shen CX, Feng Y.
    Biomed Pharmacother; 2008 Feb 06; 62(2):125-9. PubMed ID: 17764890
    [Abstract] [Full Text] [Related]

  • 11. Neointimal proliferation in canine coronary arteries. A model of restenosis permitting local and continuous drug delivery.
    Scheinowitz M, Shou M, Banai S, Gertz SD, Lazarous DF, Unger EF.
    Lab Invest; 1994 Dec 06; 71(6):813-9. PubMed ID: 7632203
    [Abstract] [Full Text] [Related]

  • 12. Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries.
    Johnson TW, Wu YX, Herdeg C, Baumbach A, Newby AC, Karsch KR, Oberhoff M.
    Arterioscler Thromb Vasc Biol; 2005 Apr 06; 25(4):754-9. PubMed ID: 15681295
    [Abstract] [Full Text] [Related]

  • 13. Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model.
    Kipshidze NN, Porter TR, Dangas G, Yazdi H, Tio F, Xie F, Hellinga D, Wolfram R, Seabron R, Waksman R, Abizaid A, Roubin G, Iyer S, Colombo A, Leon MB, Moses JW, Iversen P.
    Catheter Cardiovasc Interv; 2005 Mar 06; 64(3):389-94. PubMed ID: 15736246
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Relationship between neointimal coverage of sirolimus-eluting stents and lesion characteristics: a study with serial coronary angioscopy.
    Yamamoto M, Okamatsu K, Inami S, Takano M, Yokoyama S, Ohba T, Ibuki C, Hata N, Seino Y, Mizuno K.
    Am Heart J; 2009 Jul 06; 158(1):99-104. PubMed ID: 19540398
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.